Y-mAbs

+$0.13 (+0.89%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Y-mAbs and other ETFs, options, and stocks.

About YMAB

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory.

CEO
Thomas Gad
Employees
148
Headquarters
New York, New York
Founded
2015

YMAB Key Statistics

Market cap
647.47M
Price-Earnings ratio
—
Dividend yield
—
Average volume
612.03K
High today
$15.20
Low today
$13.99
Open price
$15.20
Volume
572.46K
52 Week high
$39.82
52 Week low
$6.50

YMAB Earnings

-$0.85
-$0.32
$0.22
$0.75
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure